Biop's optical probe will diagnose pre-cancerous and cancerous cells of the cervix, which affects more than 500k women annually, mostly young. Cervical cancer is the #2 cancer killer among women in the developing world, namely Africa, India and China.

Biop's team includes two leading US gyn's who serve on our advisory board.

Biop's probe is mobile health compatible, and creates big medical data.

Our model is sales of a disposable sleeve.